脑复聪通过抑制P2X7/NLRP1/caspase-1通路改善高糖诱导的海马神经元损伤
本研究以高糖诱导的HT22海马神经元为模型,观察含脑复聪血清的神经保护作用,并用慢病毒敲除TXNIP和P2X7R、NAC抑制氧化应激探讨机制。结果显示脑复聪可减少凋亡及IL-1β、IL-18水平,抑制NLRP1/caspase-1介导的神经元损伤,P2X7参与该过程,作用可能与抑制P2X7R/NLRP1/caspase-1通路有关。
要点
- 脑复聪含药血清可减轻高糖诱导的HT22海马神经元凋亡。
- 其保护作用与抑制P2X7R/NLRP1/caspase-1通路相关。
- 高糖环境下氧化应激升高是神经元损伤的重要启动因素。
核心结论
- 脑复聪可显著改善高糖诱导的HT22海马神经元损伤,机制可能与抑制P2X7R/NLRP1/caspase-1通路有关,为未来临床应用提供新证据。
研究设计与样本
- 采用高糖诱导的HT22海马神经元,以含脑复聪血清干预,并用慢病毒敲除TXNIP和P2X7R、NAC抑制氧化应激进行机制探讨。
主要发现
- 脑复聪降低高糖诱导HT22海马神经元的凋亡及IL-1β、IL-18水平。
- 脑复聪抑制NLRP1/caspase-1介导的神经元损伤,P2X7参与该过程。
- 高糖培养的HT22细胞氧化应激升高,可促进神经元损伤。
临床怎么用
- 提示脑复聪可能通过抑制P2X7R/NLRP1/caspase-1通路减轻高糖相关海马神经元损伤,为糖尿病认知障碍的潜在干预提供实验依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
P2X7/NLRP1/caspase-1 mediated neuronal injury plays an important role in diabetic cognitive impairment and eventually inflammatory cascade reaction. Chinese herbal compound Naofucong has been mainly used to treat cognitive disorders in Traditional Chinese Medicine The present study aimed to investigate whether its neuroprotective effects might be related to the inhibition of P2X7R/NLRP1/caspase-1 mediated neuronal injury or not. In this study, high glucose-induced HT22 hippocampal neurons were used to determine Naofucong-containing serum neuronal protective effects. Lentiviruses knock out of TXNIP and P2X7R was used to determine that protective effects of Naofucong was related to inflammatory response and P2X7/NLRP1/caspase-1 mediated neuronal injury. NAC was also used to inhibit oxidative stress, so as to determine that oxidative stress is an important starting factor for neuronal injury of HT22 cells cultured with high glucose. Naofucong decreased apoptosis, IL-1β and IL-18 levels in high glucose-induced HT22 hippocampal neuron cells. Naofucong suppressed NLRP1/caspase-1 mediated neuronal injury, and P2X7 was involved in process. HT22 cells cultured in high glucose had an internal environment with elevated oxidative stress, which could promote neuronal injury. The current study demonstrated that Naofucong could significantly improve high glucose-induced HT22 hippocampal neuron injury, which might be related to suppress P2X7R/NLRP1/caspase-1 pathway, which provides novel evidence to support the future clinical use of Naofucong.
引用
- Jing G, Wang H, Nan F, et al. Naofucong Ameliorates High Glucose Induced Hippocampal Neuron Injury Through Suppressing P2X7/NLRP1/Caspase-1 Pathway. Front Pharmacol. 2021. PMID: 34093185. doi:10.3389/fphar.2021.647116
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。